Antibody responses to flagellin C and Streptococcus gallolyticus pilus proteins in colorectal cancer.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 07 2019
Historique:
received: 19 02 2019
accepted: 10 07 2019
entrez: 28 7 2019
pubmed: 28 7 2019
medline: 3 11 2020
Statut: epublish

Résumé

Antibodies to Streptococcus gallolyticus subspecies gallolyticus (SGG) have been associated with colorectal cancer (CRC). Because SGG may correlate with impaired gut epithelia, we assessed the association of antibodies to bacterial flagellin C (FliC), a measure potentially related to this impairment, with CRC and the CRC-specific interaction with antibodies to SGG proteins. Antibodies to FliC and SGG pilus proteins Gallo2178 and Gallo2179 were measured in two independent studies, a combined study from Nijmegen and Detroit (93 CRC cases, 74 controls) and a replication data set including 576 cases and 576 controls from the Spanish multicenter multicase-control study (MCC-Spain). Logistic regression was applied to assess whether antibodies to FliC were associated with CRC and modified the association of antibodies to SGG proteins with CRC. Antibodies to FliC were associated with those to SGG Gallo2178 among CRC cases, resulting in an interaction in the association of antibodies to Gallo2178 with CRC (p = 0.007). This association was only present among individuals with high antibody responses to FliC (OR: 2.42, 95% CI: 1.45-4.06). In conclusion, our findings suggest that colorectal tumorigenesis could be accompanied by an impaired integrity of the epithelium that could result in associated increased antibody responses to bacterial proteins.

Identifiants

pubmed: 31350458
doi: 10.1038/s41598-019-47347-6
pii: 10.1038/s41598-019-47347-6
pmc: PMC6659640
doi:

Substances chimiques

Antibodies, Bacterial 0
Flagellin 12777-81-0
Fimbriae Proteins 147680-16-8

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10847

Subventions

Organisme : NCI NIH HHS
ID : R01 CA093817
Pays : United States

Références

Nutr Cancer. 2013;65(2):169-77
pubmed: 23441604
Int J Cancer. 2012 Nov 15;131(10):2294-9
pubmed: 22377818
Clin Chem. 2005 Oct;51(10):1845-53
pubmed: 16099939
Cancer. 2010 Sep 1;116(17):4014-22
pubmed: 20564125
J Natl Cancer Inst. 2013 Dec 18;105(24):1907-11
pubmed: 24316595
J Clin Invest. 2004 May;113(9):1296-306
pubmed: 15124021
Lancet. 2014 Apr 26;383(9927):1490-1502
pubmed: 24225001
Nat Rev Microbiol. 2012 Jun 25;10(8):575-82
pubmed: 22728587
Front Microbiol. 2018 Apr 03;9:614
pubmed: 29666615
PLoS Pathog. 2017 Jul 13;13(7):e1006440
pubmed: 28704539
Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):E283-E291
pubmed: 29279402
Gac Sanit. 2015 Jul-Aug;29(4):308-15
pubmed: 25613680
Cancer Prev Res (Phila). 2012 Feb;5(2):260-5
pubmed: 22012878
J Infect Dis. 2011 Apr 15;203(8):1101-9
pubmed: 21451000
J Immunol. 2006 Sep 1;177(5):2810-8
pubmed: 16920916
BMC Cancer. 2013 Feb 26;13:91
pubmed: 23442743
BMC Cancer. 2009 Nov 19;9:403
pubmed: 19925668
Front Microbiol. 2018 Apr 10;9:603
pubmed: 29692760
Int J Cancer. 2018 Jul 15;143(2):245-252
pubmed: 29377173
Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):291-301
pubmed: 26823475
Trends Microbiol. 2004 Nov;12(11):509-17
pubmed: 15488392
Sci Rep. 2018 Jan 24;8(1):1514
pubmed: 29367658
Int J Cancer. 2016 Apr 1;138(7):1670-9
pubmed: 26537841
J Infect Dis. 2011 Dec 15;204(12):1960-70
pubmed: 22043018
Int J Cancer. 2017 Sep 1;141(5):897-904
pubmed: 28477334

Auteurs

Julia Butt (J)

Infection and Cancer Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. julia.butt@duke.edu.
Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany. julia.butt@duke.edu.

Nerea Fernández de Larrea (N)

Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.

Harold Tjalsma (H)

Independent researcher. Experimental work conducted at the Department of Laboratory Medicine, Radboud University Medical Centre (RadboudUMC), Nijmegen, The Netherlands.

Rian Roelofs (R)

Department of Laboratory Medicine, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud university medical centre (Radboudumc), Nijmegen, The Netherlands.

Ikuko Kato (I)

Departments of Oncology and Pathology, Wayne State University, Detroit, Michigan, USA.

Vicente Martín (V)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
The Research Group in Gene Environment and Health Interactions, University of León, León, Spain.

Beatriz Pérez-Gómez (B)

Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Cardiovascular and Metabolic Diseases Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain.

Victor Moreno (V)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Oncology Data Analytics Program, Catalan Institute of Oncology (ICO), Hospitalet de Llobregat, Barcelona, Spain.
Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain.
Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.

Trinidad Dierssen-Sotos (T)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
University of Cantabria - IDIVAL, Santander, Spain.

Jesús Castilla (J)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Public Health Institute of Navarra, IdiSNA- Navarra Institute for Health Research, Pamplona, Spain.

Guillermo Fernández-Tardón (G)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
IUOPA, University of Oviedo, Oviedo, Spain.

Pilar Amiano (P)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Public Health Division of Gipuzkoa, BioDonostia Research institute, San Sebastian, Spain.

Dolores Salas (D)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Cancer and Public Health Area, FISABIO - Public Health, Valencia, Spain.
General Directorate Public Health, Valencian Community, Valencia, Spain.

Juan Alguacil (J)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Natural Resources, Health and Environment Research Center (RENSMA), University of Huelva, Huelva, Spain.

José Juan Jiménez-Moleón (JJ)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Granada Health Research Institute (ibs.GRANADA), Granada, Spain.
Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.

José María Huerta (JM)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.

Silvia de Sanjosé (S)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
PATH, Reproductive Health, Seattle, USA.

Rosa Del Campo (R)

Department of Microbiology, Ramón y Cajal Health Research Institute (IRYCIS), Hospital Universitario Ramón y Cajal, Madrid, Spain.
Spanish Network for Research in Infectious Diseases (REIPI), Madrid, Spain.

Manolis Kogevinas (M)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
ISGlobal, Barcelona, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
Pompeu Fabra University (UPF), Barcelona, Spain.

Marina Pollán (M)

Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.

Michael Pawlita (M)

Infection and Cancer Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Tim Waterboer (T)

Infection and Cancer Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Annemarie Boleij (A)

Department of Pathology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud university medical centre (Radboudumc), Nijmegen, The Netherlands.

Nuria Aragonés (N)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Epidemiology Section, Public Health Division, Department of Health of Madrid, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH